Regina Hodits
Management
Themis
Austria
Biography
Regina Hodits studied chemical engineering in Vienna and holds a Ph.D. in biochemistry. She started to build her extensive network in the global healthcare industry during her tenure at McKinsey. Further stations of her career were Atlas Venture and Apax Partners, for which she served on several Boards, including Bicycle Therapeutics, F-star (partly acquired by BMS), U3 Pharma (acquired by Daiichi Sankyo), Nitec Pharma (now part of Horizon Pharma NASDAQ HZPN), Egalet (NASDAQ: EGLT), and Novamed, (acquired by SciClone, NASDAQ SCLN).
Research Interest
Clinical trials, Clinical research, Clinical sciences
